Improved flexibility driving investment in disposable solutions

Biomanufacturing professionals have pinpointed improved flexibility and increased ROI as key drivers behind why they are making the move to single-use systems.
The findings come as part of a comprehensive online survey carried out by Pharma IQ who generated feedback from stakeholders around the world.
According to the survey, single-use and disposable technologies have been gaining momentum in the biopharmaceuticals industry over the past decade.
Key drivers behind this, include:

• 81% of respondents cited improved flexibility
• 30% of respondents cited reduced time to market
• 23% of respondents cited increased ROI
• 64% of respondents cited reduced cross-contamination issues

The report says that whilst the advantages of single-use technology are clear, the market is yet to reach maturity. This is partially down to the fact that the industry remains unclear on standards and regulatory guidance.
Visit for more information

Related reading:

• How many bioprocess units can you ship per flight?
• Chemical safety a leading supply chain issue in China
• ALLpaQ gets air cargo bioprocess container off the ground
• Plastic bioprocess containers: the argument stacks up
• Thermo Fisher Scientific buys biotech firm Life Technologies
• Downstream Bioprocessing Bottleneck Slowing Traffic

Author

Phill Allen

Managing Director

An in and outside the (bioprocess) box thinker, fluid management specialist Phill knows a thing or two about keeping pharma liquid logistics flowing.

Follow me